The fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the fund's investment objective. The index is a modified capitalization weighted index that includes securities of Nasdaq listed companies that are classified as either biotechnology or pharmaceutical. The fund is non-diversified.
ProShares
ETF
Equity
- years
8 holdings
$13.93
Price+2.46%
$0.33
$2.510m
Small
$13.369k
Avg Volume$3.353m
$15.02
NAV0.95%
Expense Ratio4.31%
Yield$0.60
Dividend